(Q34024617)

30 July 2017

title

Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients (English)

1 reference

30 July 2017

1 reference

Paula Freitas

1

0 references

António Sarmento

object named as

António Sarmento

8

0 references

Ana Cristina Santos

object named as

Ana Cristina Santos

4

0 references

Davide Carvalho

object named as

Davide Carvalho

2

0 references

author name string

Selma Souto

3

1 reference

30 July 2017

Sandra Xerinda

5

1 reference

30 July 2017

Rui Marques

6

1 reference

30 July 2017

Esteban Martinez

7

1 reference

30 July 2017

José Luís Medina

9

1 reference

30 July 2017

publication date

20 September 2011

1 reference

30 July 2017

published in

BMC Infectious Diseases

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

246

1 reference

Creative Commons Attribution 2.0 Generic

30 July 2017

copyright license

start time

20 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cardiovascular complications in HIV management: past, present, and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Fat distribution in men with HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

The metabolic syndrome--a new worldwide definition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Redefining lipodystrophy syndrome: risks and impact on clinical decision making

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Acquired and inherited lipodystrophies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Cardiovascular morbidity and mortality associated with the metabolic syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Prediction of Coronary Heart Disease Using Risk Factor Categories

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

5 July 2018

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Prevalence of metabolic syndrome among HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

HIV and metabolic syndrome: a comparison with the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Prevalence of HIV-associated lipodystrophy in Brazilian outpatients: relation with metabolic syndrome and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-246

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187742

Abnormal fat distribution and use of protease inhibitors

29 October 2018

1 reference

12 December 2020

Critical questions about the metabolic syndrome

1 reference

12 December 2020

Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey)

1 reference

12 December 2020

[Primary lipodystrophies]

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-11-246

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference